Alpha Fusion, Inc.
JP
EN
News&Events
ALL
ALL
EVENTS
NEWS
EVENTS
Professor Takashi Nakano, Director of the Research Center for Nuclear Physics at the University of Osaka and CTO of Alpha Fusion Inc., will give a lecture at a seminar hosted by the Kansai Pharmaceutical Industries Association (KPIA).
2026/07/24
NEWS
A feature article on our collaborator, Dr. Tadashi Watabe, Specially Appointed Associate Professor at the Institute for Radiation Sciences, the University of Osaka, has been published in Nikkei Biotechnology.
2026/06/26
EVENTS
Head of Supply Chain Development Kohno is scheduled to participate in a panel discussion at the Targeted Radiopharmaceuticals Summit US in San Diego.
2026/06/25
NEWS
Our collaborator, Dr. Tadashi Watabe, Specially Appointed Associate Professor at the Institute for Radiation Sciences, the University of Osaka, delivered a lecture at a webinar hosted by IBA.
2026/06/18
NEWS
Interview articles featuring our collaborator, Dr. Tadashi Watabe, Specially Appointed Associate Professor at the Institute for Radiation Sciences, the University of Osaka, were published in The Chugoku Shimbun and The Niigata Nippo.
2026/06/15
NEWS
Our collaborator, Dr. Tadashi Watabe, Specially Appointed Associate Professor at the Institute for Radiation Sciences, the University of Osaka, has received the JNM Best Paper Award for Clinical Investigation.
2026/05/31
NEWS
Our collaborator, Dr. Tadashi Watabe, Specially Appointed Associate Professor at the Institute for Radiation Sciences, the University of Osaka, delivered an invited talk at the 2026 SNMMI Annual Meeting held in Los Angeles.
2026/05/30
NEWS
Head of Drug Discovery Strategy Kimura has published articles in Medical Science Digest, The Cell (Monthly Journal “Saibou”), and Pharmacia.
2026/01/23
NEWS
New Clinical Trial of af-001 for Differentiated Thyroid Cancer Posted on ClinicalTrials.gov
2026/01/13
NEWS
Head of Supply Chain Development Kohno delivered a presentation at the Luncheon Seminar of the 3rd Symposium on Short-Lived RIs Application and Research
2025/11/29
NEWS
Alpha Fusion Initiates Company-Sponsored Clinical Trial of Alpha-Emitting Radiopharmaceutical af-001 in Patients with Differentiated Thyroid Cancer
2025/10/31
EVENTS
Head of Supply Chain Development Kohno presented at the 7th Targeted Radiopharmaceuticals Summit Europe.
2025/11/12
EVENTS
CEO Fujioka and Head of Supply Chain Development Kohno attended Bio-Europe 2025 (Vienna).
2025/11/03 - 2025/11/05
NEWS
A clinical trial report on the investigator-initiated Alpha-T1 study by our collaborator, Associate Professor/Lecturer Dr. Watabe from the University of Osaka Graduate School of Medicine, was published in The Journal of Nuclear Medicine.
2025/10/07
EVENTS
A review article on At-PSMA-5 by our collaborator, Associate Professor/Lecturer Dr. Watabe from the University of Osaka Graduate School of Medicine, was published in Seminars in Nuclear Medicine.
2025/09/30
NEWS
A clinical trial report on the investigator-initiated Alpha-T1 study by our collaborator, Associate Professor/Lecturer Dr. Watabe from the University of Osaka Graduate School of Medicine, was published in The Journal of Nuclear Medicine.
2025/09/26
NEWS
Head of Supply Chain Development Kohno presented and participated in a panel discussion at the 6th VC Consortium Special Event
2025/08/28
NEWS
Alpha Fusion Inc. Selected for the 2025 Japan–U.S. Innovation Awards Innovation Showcase
2025/07/17
NEWS
Alpha Fusion, Inc. and Curadh MTR, Inc. to Enter into Strategic Partnership to Advance Global Development of Astatine-211 Based Radiopharmaceuticals
2025/07/10
NEWS
Alpha Fusion Initiates Joint Research with Mitsubishi Tanabe Pharma and Veneno Technologies
2025/06/30
1-20/28
PREV
1
2
NEXT